Guided IMagery and Patient Satisfaction (GIMPS) Following Urogynecological Surgery (GIMPS)
Pelvic Organ Prolapse
About this trial
This is an interventional supportive care trial for Pelvic Organ Prolapse focused on measuring Pelvic Organ Prolapse, Surgery
Eligibility Criteria
Inclusion Criteria:
- routine vaginal or laparoscopic surgery for pelvic organ prolapse planned ≥ 1 week from enrollment
- a planned overnight hospital stay
- commitment to listen to a 15 minute audio Compact Disc daily
- proficiency in English.
Exclusion Criteria:
- Not having routine vaginal or laparoscopic surgery for pelvic organ prolapse planned ≥ 1 week from enrollment
- Not a planned overnight hospital stay
- Unable to commitment to listen to a 15 minute audio Compact Disc daily
- Not proficiency in English.
Sites / Locations
- Loyola University Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Guided IMagery (GIM)
Standard of Care (SOC)
If randomized to GIM, they will then be given an audio Compact Disc. Patients will be instructed to listen to the recording least once per day in a calm location during the week leading up to surgery. They will then be seen prior to surgery in the surgical waiting area where they will evaluated for anxiety, preparedness and study compliance.
Each participant will complete a baseline set of questionnaires. The Pelvic Floor Distress Inventory (PFDI) is a 20 question self-administered questionnaire on the presence and both of pelvic floor symptoms . The Pelvic Organ Prolapse Quantification System (POPQ) measures the topography of the vagina and is considered to be gold standard for quantifying prolapse . The State-Trait Anxiety Inventory (STAI) has been used extensively in research and clinical practice since its introduction in 1966 and is the most widely cited measure of anxiety. New measurements at the 6-week follow-up appointment will include the Patient Global Impression of Improvement (PGII), and a postoperative questionnaire eliciting overall satisfaction and development of new pelvic symptoms.